Aurobindo Pharma Ltd Corporate Actions

Top Stocks for Today - 29th April 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: Gensol Engineering, Oberoi Realty, TVS Motor Company, etc.

Aurobindo Pharma Gets USFDA Nod for Leukemia Drug Dasatinib

 Copy Link

Aurobindo Pharma is going to launch Dasatinib in Q1 FY26, which will be in line with its plans to enhance its oncology portfolio in the US generics market.

Aurobindo Pharma Gets 11 FDA Observations After US Plant Inspection

 Copy Link

Following the audit, the US FDA issued a Form 483 with 11 observations at closure, which Aurobindo Pharma described as small procedural observations.

Top Stocks for Today - 15th April 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: GAIL, Zydus Lifesciences, Aurobindo Pharma, etc.

Aurobindo Pharma’s CuraTeQ completes phase I of bone drug study

 Copy Link

As per the company, the drug functions by blocking a protein called RANKL, which is responsible for breaking down bone tissue.

Top Stocks for Today - 11th April 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: BHEL, Coromandel International, Aurobindo Pharma, etc.

Aurobindo Pharma’s Eugia gets 5 observations from USFDA

 Copy Link

As per the company’s filing with the bourses, the inspection was concluded with five procedural observations.

Aurobindo Pharma Q3 Profit Falls 9.7% YoY, Revenue Up 8.5%

 Copy Link

Revenue increased by 8.5% YoY to ₹7,978.5 crore.

Aurobindo Pharma’s Telangana API Facility Gets USFDA VAI Classification

 Copy Link

The USFDA inspected the Unit 2 API manufacturing facility of Apitoria Pharma during September 23 to September 27, 2024

Aurobindo Pharma Gains UK Approval for Cancer Drug Bevqolva

 Copy Link

This is a medicine used to treat specific kinds of cancer. It can be administered only via an infusion.